Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Daily News

For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI

Michael O'Riordan

February 23, 2023

News Daily News

Early Redo TAVI Outcomes Look Good, but ‘Far From Definitive’

Michael O'Riordan

July 18, 2022

News Daily News

Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut

Michael O'Riordan

October 28, 2020

Lancet COVID-19 Hydroxychloroquine Study Faces ‘Data Integrity’ Questions

News Daily News

TAVR Bests Surgical Redo for Failed Bioprostheses: Early Data

Michael O'Riordan

June 01, 2020

News Daily News

Evolut Valves: Initial Positioning Can Be Optimized for Future Coronary Access

Michael O'Riordan

July 10, 2019

News Conference News TVT 2019

PCI During or After TAVR No Riskier Than PCI Before Valve Replacement

Michael O'Riordan

June 13, 2019

News Opinion Editor's Corner TCT 2018

TCT 2018, Day Four: Bioresorbable Scaffolds, Renal Denervation, Head-to-Head TAVR, INOCA, and . . . That’s a Wrap!

Shelley Wood

September 25, 2018

News Conference News EuroPCR 2017

My Takeaways From EuroPCR 2017: Everything Perfect, Until It’s Not

Shelley Wood

June 02, 2017

News Conference News EuroPCR 2017

EuroPCR 2017: New Stents, New Questions for PCI Today and Tomorrow as Angioplasty Turns 40

Shelley Wood

May 12, 2017

News Industry News

Boston Scientific Announces Scheduled Presentations At TCT 2015

October 08, 2015

News Daily News

Moderate-to-Severe Mitral Regurgitation Signals Elevated Mortality Risk After TAVR

Todd Neale

June 18, 2015

News Daily News

一个比利时登记处的报告显示，在经股动脉TAVR中采取Sapien、CoreValve时的3年生存率结果相似

Yael L. Maxwell

June 03, 2015

News Daily News

Un Registro Belga Confirma una Supervivencia Similar a los 3 Años con las Válvulas Sapien y CoreValve en la realización de TAVR Transfemorales

Yael L. Maxwell

June 03, 2015

News Daily News

Belgian Registry Reports Similar 3-Year Survival for Sapien, CoreValve in Transfemoral TAVR

Yael L. Maxwell

June 03, 2015

News Conference News

ACC Scientific Session-i2 Summit 2011: The Devil Is in the Details

Caitlin E. Cox

April 08, 2011

Advertisement

What’s Going to Be Hot at TCT 2025

For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI

Early Redo TAVI Outcomes Look Good, but ‘Far From Definitive’

Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut

TAVR Bests Surgical Redo for Failed Bioprostheses: Early Data

Evolut Valves: Initial Positioning Can Be Optimized for Future Coronary Access

PCI During or After TAVR No Riskier Than PCI Before Valve Replacement

TCT 2018, Day Four: Bioresorbable Scaffolds, Renal Denervation, Head-to-Head TAVR, INOCA, and . . . That’s a Wrap!

My Takeaways From EuroPCR 2017: Everything Perfect, Until It’s Not

EuroPCR 2017: New Stents, New Questions for PCI Today and Tomorrow as Angioplasty Turns 40

Boston Scientific Announces Scheduled Presentations At TCT 2015

Moderate-to-Severe Mitral Regurgitation Signals Elevated Mortality Risk After TAVR

一个比利时登记处的报告显示，在经股动脉TAVR中采取Sapien、CoreValve时的3年生存率结果相似

Un Registro Belga Confirma una Supervivencia Similar a los 3 Años con las Válvulas Sapien y CoreValve en la realización de TAVR Transfemorales

Belgian Registry Reports Similar 3-Year Survival for Sapien, CoreValve in Transfemoral TAVR

ACC Scientific Session-i2 Summit 2011: The Devil Is in the Details

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content